SAN FRANCISCO, Oct. 14, 2021 (GLOBE NEWSWIRE) — PepperLime Health Acquisition Corporation (the “Company”), a Cayman Islands exempted firm that could be a clean examine firm fashioned for the aim of getting into right into a merger, share trade, asset acquisition, share buy, reorganization or related business mixture with a number of companies, in the present day introduced the pricing of its preliminary public providing of 15,000,000 items at a value of $10.00 per unit. The Company has granted the underwriter a 45-day choice to buy as much as an extra 2,250,000 items on the preliminary public providing value to cowl over-allotments, if any.
While the Company might pursue an preliminary business mixture goal in any business or business, the Company intends to focus on corporations on the intersection of know-how and shopper well being and wellness. The proceeds of the preliminary public providing might be used to fund the business mixture.
The items might be listed on the Nasdaq Global Market and commerce below the ticker image “PEPLU” on or promptly after the date hereof. Each unit consists of 1 Class A atypical share of the Company and one-half of 1 warrant. Each entire warrant entitles the holder thereof to buy one Class A atypical share of the Company at a value of $11.50 per share. Once the securities comprising the items start separate buying and selling, the Class A atypical shares and warrants are anticipated to be listed on the Nasdaq Global Market below the symbols “PEPL” and “PEPLW,” respectively. The providing is anticipated to shut on October 19, 2021, topic to customary closing situations.
Oppenheimer & Co. Inc. acted as the only real underwriter for the providing.
The providing is being made solely via a prospectus. When accessible, copies of the prospectus could also be obtained from: Oppenheimer & Co. Inc., Attn: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, New York 10004, phone: (212) 667-8055 or e mail: [email protected].
A registration assertion regarding the securities turned efficient on Oct. 14, 2021 in accordance with Section 8(a) of the Securities Act of 1933, as amended. This press launch shall not represent a suggestion to promote or the solicitation of a suggestion to purchase, nor shall there be any sale of those securities in any state or jurisdiction by which such provide, solicitation, or sale can be illegal previous to registration or qualification below the securities legal guidelines of any such state or jurisdiction.
This press launch accommodates statements that represent “forward-looking statements,” together with with respect to the closing of the proposed preliminary public providing and the anticipated use of the online proceeds. No assurance might be on condition that the providing mentioned above might be accomplished on the phrases described, or in any respect, or that the online proceeds of the providing might be used as indicated. Forward-looking statements are topic to quite a few situations, a lot of that are past the management of the Company, together with these set forth within the Risk Factors part of the Company’s registration assertion and preliminary prospectus for the Company’s providing filed with the Securities and Exchange Commission (“SEC”). Copies can be found on the SEC’s web site, www.sec.gov. The Company undertakes no obligation to replace these statements for revisions or adjustments after the date of this launch, besides as required by legislation.
Contact
PepperLime Health Acquisition Corporation
www.pepperlimehealth.com
Ramzi Haidamus
(415) 263-9939
Related Images
Image 1: PepperLime Health
This content material was issued by means of the press launch distribution service at Newswire.com.
